Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Jan-Feb;54(1):22-24.
doi: 10.1016/j.transproceed.2021.09.067. Epub 2021 Nov 12.

Hospital Management and Ambulatory Patient Care After COVID-19 Infection in Kidney Transplant

Magdalena Terán Redondo  1 , Claudia Muñoz Martínez  2 , Pedro Rosa Guerrero  2 , M Luisa Agüera Morales  2 , Álvaro Torres De Rueda  2 , Alberto Rodríguez Benot  2
Affiliations
Observational Study

Hospital Management and Ambulatory Patient Care After COVID-19 Infection in Kidney Transplant

Magdalena Terán Redondo et al. Transplant Proc. 2022 Jan-Feb.

Abstract

Background: A large number of registries have been collected for kidney transplant recipients infected with COVID-19.

Methods: From March 2020 to April 2021, our team conducted an observational study, which included all patients who showed a polymerase chain reaction positive for COVID-19. Patients were divided into 2 groups: patients who required ambulatory care and patients who needed hospital admission.

Results: A total of 76 kidney transplant recipients were infected with COVID-19. A total of 33% required hospital admission and 65% received ambulatory treatment; 28% of our patients were asymptomatic and 6.8% died. Immunosuppressive treatment was modified in both study groups, and there were not any acute rejection episodes or changes in the human leukocyte antigen antibodies profile in our patients during our clinical trial.

Conclusions: In our study there was a significant percentage of patients who did not require hospital admission compared with other studies. In addition, we think that the reduction of immunosuppression can be a safe and reliable treatment.

PubMed Disclaimer

Figures

Fig 1
Fig 1
Management of immunosuppressive therapy to the different study groups. MMF, mycophenolate mofetil.
See this image and copyright information in PMC

References

    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727–733. - PMC - PubMed
    1. Carlos III Health Institute. COVID-19 situation in Spain, https://www.isciii.es; 2021 [accessed 11.08.21].
    1. Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, Martínez-Fernández JR, Crespo M, Gayoso J, et al. COVID-19 in transplant recipients: the Spanish experience. Am J Transplant. 2021;21:1825–1837. - PMC - PubMed
    1. Coll E, Padilla M, Hinojal R, Peña L, Dominguez-Gil B. Recommendations on management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients. Ministerio de Sanidad. Organización Nacional de Trasplantes. 2021
    1. Villanego F, Mazuecos A, Pérez-Flores IM, Moreso F, Andrés A, Jiménez-Martín C, et al. Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry. Am J Transplant. 2021;21:2573–2582. - PMC - PubMed

Publication types

Substances